plerixafor has been researched along with Arteriosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyer, O; Brakenhielm, E; Freguin-Bouillant, C; Henry, JP; Lallemand, F; Plissonnier, D; Roux, N; Thuillez, C | 1 |
| Alkhatib, B; David, N; Fréguin-Bouilland, C; Godin, M; Henry, JP; Lallemand, F; Plissonnier, D; Thuillez, C | 1 |
2 other study(ies) available for plerixafor and Arteriosclerosis
| Article | Year |
|---|---|
Progenitor cell mobilizing treatments prevent experimental transplant arteriosclerosis.
Topics: Animals; Anti-HIV Agents; Anticholesteremic Agents; Anticoagulants; Aorta; Arteriosclerosis; Benzylamines; Cyclams; Endothelium, Vascular; Graft Rejection; Green Fluorescent Proteins; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Molecular Weight; Polysaccharides; Simvastatin; Transplantation, Homologous; Tunica Intima | 2012 |
Low molecular weight fucoidan prevents neointimal hyperplasia after aortic allografting.
Topics: Animals; Aorta; Arteriosclerosis; Benzylamines; Chemokine CXCL12; Chemokines, CXC; Cyclams; Endothelium, Vascular; Heterocyclic Compounds; Hyperplasia; Male; Molecular Weight; Polysaccharides; Postoperative Complications; Rats; Rats, Inbred BN; Rats, Inbred Lew; Receptors, CXCR4; Transplantation; Transplantation, Homologous; Tunica Intima | 2007 |